StrokeDx Raises Oversubscribed $5 Million Seed Prime Round to Advance Next-Generation Stroke Technology
StrokeDx, a pioneering stroke technology company, secures funding to develop and commercialize advanced technologies for safe cerebrovascular monitoring.
PASADENA, Calif.–(BUSINESS WIRE)–StrokeDx, a pioneer in next-generation stroke technology, today announced the successful closing of $5 million in Series Seed Prime funding. The oversubscribed round was led by DigiTx Partners, with participation by Freeflow Ventures and other existing investors with extensive accomplishments across neuroradiology, stroke, and medical devices. David J. Kim, MD, Managing Director of DigiTx Partners, will be joining the board. To date, StrokeDx’s technology has raised almost $10 million, including a National Institutes of Health (NIH) R01 Grant. This latest investment will support further clinical validation of StrokeDx’s groundbreaking technology and the expansion of its commercial efforts.
